uniQure
QURE
#5575
Rank
NZ$2.45 B
Marketcap
NZ$34.94
Share price
-5.09%
Change (1 day)
-29.81%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2026 (TTM): -NZ$0.41 Billion

According to uniQure's latest financial reports the company's current earnings are NZ$20.16 Million. In 2025 the company made an earning of -NZ$0.36 Billion, an increase over its 2024 earnings that were of -NZ$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.41 Billion16.52%
2025 -NZ$0.36 Billion-18.47%
2024 -NZ$0.44 Billion-22.65%
2023 -NZ$0.56 Billion139.01%
2022 -NZ$0.24 Billion-138.54%
2021 NZ$0.60 B-335.29%
2020 -NZ$0.26 Billion13.88%
2019 -NZ$0.23 Billion49.51%
2018 -NZ$0.16 Billion4.55%
2017 -NZ$0.15 Billion12.65%
2016 -NZ$0.13 Billion-9.59%
2015 -NZ$0.15 Billion66.95%
2014 -NZ$85.05 Million30.8%
2013 -NZ$65.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$20.11 B-4,826.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$14.17 B-3,430.95%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-NZ$0.21 Billion-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-NZ$0.37 Billion-14.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$79.46 M-118.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-NZ$1.25 Billion 192.82%๐Ÿ‡บ๐Ÿ‡ธ USA